DPIIT recognised startup Government of India
Startup India
Sternum Pharmaceuticals Private Limited
Sternum Pharmaceuticals Private Limited - chemicals in Ayodhya, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹11.99 Lakh
Latest filing
Net loss · FY 2023
₹9,142
Net margin -0.8%
EBITDA · FY 2023
-₹2,890
EBITDA margin -0.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹18.95 Lakh
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
3
As per MCA filings
About Sternum Pharmaceuticals Private Limited
Data last updated:
Sternum Pharmaceuticals Private Limited is a private limited company based in Ayodhya, Uttar Pradesh, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 05 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24100UP2019PTC119829.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Siddharth Dewvedi and Pooja Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Nirmal Nagar Colony Booth No – 4 Shahnawazpur Ayodhya, Uttar Pradesh, India – 224001.
As per the financials filed for FY 2023, the company reported a revenue of ₹11.99 Lakh. For the same year it recorded a net loss of ₹9,142 (net margin -0.8%) and EBITDA of -₹2,890 (EBITDA margin -0.2%).
As per MCA filings, the company has open charges of ₹18.95 Lakh on record.
Sternum Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-24-0003927).
Company details
CIN U24100UP2019PTC119829
Registration Number 119829
Incorporation Date 05 August 2019
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-UP-24-0003927
Key People
Siddharth Dewvedi Director Pooja Tiwari Additional Director Kamal Misra Additional Director Recognitions & Rankings of Sternum Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-24-0003927
Contact details
Sternum Pharmaceuticals Private Limited's registered office is in Ayodhya, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressNirmal Nagar Colony Booth No – 4 Shahnawazpur Ayodhya, Uttar Pradesh, India – 224001
- IndustryChemicals, Manufacturing, Basic Chemical
To see the full contact details of Sternum Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Sternum Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sternum Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sternum Pharmaceuticals Private Limited, buy the company report.
Financials of Sternum Pharmaceuticals Private Limited
FY 2025 filings availableSternum Pharmaceuticals Private Limited reported revenue of ₹11.99 Lakh for FY 2023.
Revenue · FY 2023
₹11.99 Lakh
Net loss · FY 2023
₹9,142 margin -0.8%
EBITDA · FY 2023
-₹2,890 margin -0.2%
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹2,890 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹9,142 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -0.2% | |||
| Net Profit Margin | -0.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Sternum Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sternum Pharmaceuticals Private Limited
Sternum Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Siddharth Dewvedi Also directs: Smedisyn Pharma Private Limited | Director | 05 Aug 2019 | 7 Years 2 Months | Current |
| Pooja Tiwari | Additional Director | 23 May 2023 | 3 Years 5 Months | Current |
| Kamal Misra | Additional Director | 28 Jan 2026 | 0 Years 9 Months | Current |
Peer comparison
Sternum Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Souris Pharmaceuticals Private Limited | ₹12.06 Lakh (FY 2025) | -7.0% | Bangalore, Karnataka, India | |||
| Zeinac Pharmaceuticals Private Limited | ₹12.05 Lakh (FY 2024) | 47.0% | Bareilly, Uttar Pradesh, India | |||
| Klyrich Pharmaceuticals Private Limited | ₹11.99 Lakh (FY 2025) | -18.0% | Lucknow, Uttar Pradesh, India | |||
| Sternum Pharmaceuticals Private Limitedthis company | ₹11.99 Lakh (FY 2023) | -₹9,142 | -0.8% | Ayodhya, Uttar Pradesh, India | ||
| Singulans Pharmaceuticals Private Limited | ₹11.97 Lakh (FY 2024) | 4428.0% | Lucknow, Uttar Pradesh, India | |||
| Primax Pharmaceuticals Private Limited | ₹11.89 Lakh (FY 2018) | 302.0% | Dhanbad, Jharkhand, India | |||
| Neowick Pharmaceuticals Private Limited | ₹11.87 Lakh (FY 2024) | 177.0% | Gorakhpur, Uttar Pradesh, India |
To see the full peer comparison of Sternum Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹18.95 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Dec 2025 | 101214956 | Uco Bank | ₹7.5 Lakh | Open | |
| 03 Sep 2025 | 101155254 | Hdfc Bank Limited | ₹3.05 Lakh | Open | |
| 04 Mar 2024 | 100909368 | Hdfc Bank Limited | ₹8.4 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Sternum Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sternum Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sternum Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sternum Pharmaceuticals Private Limited has 7 board changes on record since 2019: 4 appointments and 3 cessations. The latest: Kamal Misra was appointed as Additional Director on 28 Jan 2026.
Appointed
Kamal Misra was appointed as Additional Director.
Charges
A charge with Uco Bank amounted to Rs. 7.50 Lakh with Charge ID 101214956 was registered on 19 Dec 2025.
AGM
Sternum Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 3.05 Lakh with Charge ID 101155254 was registered on 03 Sep 2025.
Ceased
Kirti Tiwari ceased to be Additional Director.
Ceased
Rohit Dwivedi ceased to be Director.
Filing
Sternum Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 8.40 Lakh with Charge ID 100909368 was registered on 04 Mar 2024.
Appointed
Pooja Tiwari was appointed as Additional Director.
Appointed
Rohit Dwivedi was appointed as Director.
Ceased
Atul Kumar Shukla ceased to be Director.
Appointed
Siddharth Dewvedi was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Sternum Pharmaceuticals is an active private limited company based in Ayodhya, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 05 August 2019 (7+ years old) and is registered under CIN U24100UP2019PTC119829.
Sternum Pharmaceuticals has 3 current directors:
- Siddharth Dewvedi - Director
- Pooja Tiwari - Additional Director
- Kamal Misra - Additional Director
The latest financial statements of Sternum Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Sternum Pharmaceuticals is U24100UP2019PTC119829. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sternum Pharmaceuticals was incorporated on 05 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Sternum Pharmaceuticals by revenue are Souris Pharmaceuticals Private Limited, Zeinac Pharmaceuticals Private Limited, Klyrich Pharmaceuticals Private Limited, Singulans Pharmaceuticals Private Limited, Primax Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Kamal Misra was appointed as Additional Director on 28 Jan 2026. Kirti Tiwari ceased to be Additional Director on 01 Apr 2025. Rohit Dwivedi ceased to be Director on 01 Apr 2025. Sternum Pharmaceuticals has 7 board changes on record in total.
Yes, Sternum Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Sternum Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-24-0003927).
The registered office of Sternum Pharmaceuticals is at Nirmal Nagar Colony Booth No – 4 Shahnawazpur Ayodhya, Uttar Pradesh, India – 224001.
Sternum Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages